Fig 1.
Flow chart of the study population that underwent PCI between 2008 and 2019 in the Korean National Health Insurance Service database.
PCI, percutaneous coronary intervention; RA, rheumatoid arthritis; MI, myocardial infarction; HF, heart failure; BMI, body mass index.
Table 1.
Baseline characteristics of the included patients.
Table 2.
Procedural characteristics of the included patients at PCI index date.
Table 3.
Risk of clinical outcomes in patients with and without RA.
Fig 2.
Survival rates from MACE in patients without RA and patients with RA in the PCI cohort.
MACE, major adverse cardiovascular events; RA, rheumatoid arthritis; PCI, percutaneous coronary intervention.
Fig 3.
Survival rates from (A) hospitalized myocardial infarction; (B) stroke or transient ischemic attack; (C) coronary revascularization; and (D) all-cause mortality in patients without RA and patients with RA in the PCI cohort. RA, rheumatoid arthritis; PCI, percutaneous coronary intervention.
Fig 4.
Forest plot for the association between rheumatoid arthritis and the risk of MACE among the subgroups.
MACE, major adverse cardiovascular events; ACS, acute coronary syndrome; HR, hazard r.
Table 4.
The risk of MACE in patients with and without RA according to the subgroups.